Literature DB >> 2775628

Potential artifacts in the use of caffeine to determine acetylation phenotype.

B Lorenzo1, M M Reidenberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2775628      PMCID: PMC1379909          DOI: 10.1111/j.1365-2125.1989.tb05420.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  2 in total

1.  Interindividual and intraindividual variability in acetylation: characterization with caffeine.

Authors:  B G Hardy; C Lemieux; S E Walker; W R Bartle
Journal:  Clin Pharmacol Ther       Date:  1988-08       Impact factor: 6.875

2.  A simple test for acetylator phenotype using caffeine.

Authors:  D M Grant; B K Tang; W Kalow
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

  2 in total
  5 in total

Review 1.  Assessment of liver metabolic function. Clinical implications.

Authors:  J Brockmöller; I Roots
Journal:  Clin Pharmacokinet       Date:  1994-09       Impact factor: 6.447

2.  NAT2 and CYP1A2 phenotyping with caffeine: head-to-head comparison of AFMU vs. AAMU in the urine metabolite ratios.

Authors:  A Nyéki; T Buclin; J Biollaz; L A Decosterd
Journal:  Br J Clin Pharmacol       Date:  2003-01       Impact factor: 4.335

3.  A convenient five-drug cocktail for the assessment of major drug metabolizing enzymes: a pilot study.

Authors:  Ashish Sharma; Sylvie Pilote; Pierre M Bélanger; Marie Arsenault; Bettina A Hamelin
Journal:  Br J Clin Pharmacol       Date:  2004-09       Impact factor: 4.335

Review 4.  Structure/function evaluations of single nucleotide polymorphisms in human N-acetyltransferase 2.

Authors:  Jason M Walraven; Yu Zang; John O Trent; David W Hein
Journal:  Curr Drug Metab       Date:  2008-07       Impact factor: 3.731

Review 5.  N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk.

Authors:  D W Hein
Journal:  Oncogene       Date:  2006-03-13       Impact factor: 9.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.